Abstract Details

Title Migraine Patients Exhibit Risk Of Medication Overuse Headache With Sustained Triptan Treatment - Results From A Large-Scale Real-World Claims Analysis

Topic Headache

Presentation(s) Headache Posters (7:00 AM-5:00 PM)

Poster/Presentation
Number 091

Background

Triptans are the current standard of care for the acute treatment of moderate-to-severe migraine. While triptan use has been associated with MOH, there are few studies describing the magnitude of risk for MOH according to triptan exposure in real-world practice.